🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these accounts privately for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of members share comparison photos, injection guides and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could result in users injecting substances of unknown origin.

Several experts said the popularity for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.

Service Response and Content Removal

Based on TikTok, the service has removed problematic material and prohibited associated hashtags and query recommendations. The organization said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, positive testimonials and detailed guides for preparing or injecting at home.

Within moments of entering one group, a seller posted contact information, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.

Item Information and Pricing

Within these groups, messages show dark colored packages with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram said it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has already encountered patients harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly significant health risks”.